in focus
Percentage of donor organs recovered for transplant in the U.S. with machine perfusion intended or performed by donation quarter and organ
Quarters from April 1, 2015 to December 31, 2018. Based on data from the national Organ Procurement and Transplantation Network (OPTN).
Lung perfusion has more than tripled since 2015, growing from 1.7 percent to 6.3 percent and potentially expanding the pool of organs available for transplant.
The proportion of livers being treated with this transformative technology (including normothermic, hypothermic and other perfusion), also showed similar steady growth, jumping from just .1 percent in 2016 to 1.4 percent by the end of 2018. The OPTN began collecting data (from the Deceased Donor Registration) on the percentage of donor organs intended for ex vivo normothermic machine perfusion (NMP) and their location four years ago.
Read about the potential impact of NMP on transplantation and meet the companies leading the way in its development.
in focus
Number of donor organs (heart, liver, and lung) recovered for transplant in the U.S. with machine perfusion intended or performed
Based on data from the national Organ Procurement and Transplantation Network (OPTN).
In focus
Preserving candidate wait time during temporary inactivation due to COVID-19
Altering organ acceptance criteria protects candidates at risk of COVID-19 from losing accrued wait time.
OPO testing of deceased donors for COVID-19 ensures patient safety
Recent report shows 100 percent COVID-19 donor testing by OPOs.
Center effects greatly affect kidney access disparity
Research shows center effects are the top driver of kidney access disparities, but DSA effects still remain
Using machine learning to improve kidney allocation rates
Carlos Martinez and Andrew Placona were among more than two dozen UNOS researchers to present at the 2020 American Transplant Congress.
